News

ASCO 2026: Mobile app for symptom monitoring could help people with advanced cancer maintain their quality of life

ASCO 2026: More accessible oral chemotherapy and ultra-low-dose immunotherapy combo may improve survival and reduce side effects for advanced head and neck cancer

ASCO 2026: Ivonescimab may improve overall survival in patients with advanced squamous non-small cell lung cancer

ASCO 2026: Potential new targeted treatment option for people with localised high-risk prostate cancer

ASCO 2026: Selpercatinib shows decrease in risk of disease recurrence or death as adjuvant therapy for early-stage RET fusion-positive NSCLC

ASCO 2026: Daraxonrasib doubles median overall survival in metastatic pancreatic cancer

ASCO 2026: Addition of immunotherapy continues to show survival benefit in prolonged follow-up in primary advanced stage or recurrent endometrial cancer

ASCO 2026: Targeted drug outperforms chemotherapy for patients with hard-to-treat lung cancer

Lifestyle can protect childhood cancer survivors

ASCO 2026: Some breast cancer patients with sentinel lymph node spread can safely skip axillary lymph node dissection

ASCO 2026: Galleri early detection test may shift timing of cancer detection, reducing stage IV diagnoses

ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma